HealthCare Royalty Partners logo

HealthCare Royalty Partners

North America, Connecticut, United States, Stamford

Description

HealthCare Royalty Partners is a global investment firm that partners with healthcare companies, non-profit institutions and inventors.

Investor Profile

HealthCare Royalty Partners has made 27 investments, with 5 in the past 12 months and 78% as lead.

Stage Focus

  • Post Ipo Debt (59%)
  • Private Equity (19%)
  • Series D (4%)
  • Series E (4%)
  • Series G (4%)
  • Debt Financing (4%)
  • Series A (4%)
  • Post Ipo Equity (4%)

Country Focus

  • United States (93%)
  • Switzerland (4%)
  • France (4%)

Industry Focus

  • Biotechnology
  • Health Care
  • Therapeutics
  • Medical
  • Medical Device
  • Biopharma
  • Pharmaceutical
  • Nanotechnology
  • Clinical Trials
  • Hospital
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HealthCare Royalty Partners frequently co-invest with?

Accuitive Medical Ventures
North America, Georgia, United States, Duluth
Co-Investments: 2
The Carlyle Group
North America, District of Columbia, United States, Washington
Co-Investments: 2
SV Health Investors
North America, Massachusetts, United States, Boston
Co-Investments: 2
Kleiner Perkins
North America, California, United States, Menlo Park
Co-Investments: 2
Athyrium Capital Management LP
North America, New York, United States, New York
Co-Investments: 2
Bausch & Lomb
North America, New York, United States, Rochester
Co-Investments: 2
InterWest Partners
North America, California, United States, Menlo Park
Co-Investments: 2
VL
North America, New York, United States, New York
Co-Investments: 2
Versant Ventures
North America, California, United States, Menlo Park
Co-Investments: 2
Medtronic
North America, Minnesota, United States, Minneapolis
Co-Investments: 2

What are some of recent deals done by HealthCare Royalty Partners?

GENFIT

Loos, Nord-Pas-de-Calais, France

GENFIT is a late-stage biopharmaceutical company.

BiopharmaBiotechnologyHealth Care
Post Ipo DebtJan 30, 2025
Amount Raised: $135,538,651
Esperion

Ann Arbor, Michigan, United States

Esperion discovers and develops pharmaceutical products for the treatment of cardiovascular and metabolic diseases.

BiotechnologyHealth CareMedicalPharmaceutical
Post Ipo DebtDec 13, 2024
Amount Raised: $250,000,000
Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo EquitySep 11, 2024
Amount Raised: $67,500,000
TG Therapeutics

New York, New York, United States

TG Therapeutics, a biopharmaceutical company, develops agents for the treatment of hematologic malignancies and autoimmune disorders.

BiotechnologyHealth CareTherapeutics
Post Ipo DebtAug 6, 2024
Amount Raised: $250,000,000
OPKO Health

Miami, Florida, United States

Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.

BiotechnologyHealth DiagnosticsPharmaceutical
Post Ipo DebtJul 17, 2024
Amount Raised: $250,000,000
Zevra Therapeutics

Orlando, Florida, United States

Zevra Therapeutics is a biopharmaceutical company focused on discovering and developing therapies for pain, ADHD, and other CNS diseases.

BiotechnologyPharmaceuticalTherapeutics
Post Ipo DebtApr 10, 2024
Amount Raised: $60,000,000
Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo DebtJan 3, 2024
Amount Raised: $25,000,000
Cara Therapeutics

Shelton, Connecticut, United States

Cara Therapeutics is a biotechnology company focused on developing therapeutics to treat diseases associated with pain and inflammation.

BiotechnologyHealth CareTherapeutics
Post Ipo DebtNov 2, 2023
Amount Raised: $40,000,000
Liquidia Technologies

Morrisville, North Carolina, United States

Liquidia Technologies is a clinical biopharmaceutical company focused on the development and commercialization of human therapeutics.

BiopharmaBiotechnologyHealth CareNanotechnologyTherapeutics
Post Ipo DebtJan 9, 2023
Amount Raised: $32,500,000
Clearside Biomedical

Alpharetta, Georgia, United States

Clearside BioMedical is an ophthalmic company that specializes in the research, development, and commercialization of therapeutic products.

BiotechnologyHealth CareMedical DevicePharmaceuticalTherapeutics
Post Ipo DebtAug 8, 2022
Amount Raised: $65,000,000